LRCX monthly performance report
View LRCX's monthly returns, drawdown, and seasonality trends — updated every month.
LRCX monthly report
—
Key takeaways
- Lam Research (LRCX) closed November 2026 at $225.92, down 5.52% for the month and +47.35% over the trailing 12 months.
- Year-to-date, LRCX is +31.98%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading −20.31% versus its 200-day moving average ($283.50), a cautious technical signal.
- Over the past three years, LRCX has outperformed the S&P 500 by +164.12%, with a relative strength index reading of 195.8.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
Lam Research ended November 2026 at $225.92, posting a monthly return of −5.52%. The S&P 500 returned −0.18% over the same window, leaving relative performance at −5.34%.
The current quarter stands at −31.23% (Q4 2026 (QTD)), while medium-term trend remains soft: price is −20.31% versus the 200-day moving average ($283.50).
Year-to-date, LRCX is +31.98% against SPY +10.62%, a gap of +21.35%. The stock is currently −48.48% below its 52-week high, with maximum 3-year drawdown at −57.26%.
| Period | LRCX | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −3.36% | −0.36% | −3.00% |
| 1 Week | +12.71% | +2.59% | +10.12% |
| 1 Month | −5.52% | −0.18% | −5.34% |
| 3 Months | −34.30% | −2.37% | −31.93% |
| 6 Months | −24.48% | +0.83% | −25.31% |
| YTD | +31.98% | +10.62% | +21.35% |
| 12 Months | +47.35% | +12.25% | +35.10% |
| 3 Years | +235.49% | +71.37% | +164.12% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jan 2026 | +36.38% |
| #2 | Jun 2026 | +36.19% |
| #3 | Sep 2025 | +33.70% |
| #4 | May 2026 | +23.39% |
| #5 | Nov 2023 | +21.71% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | −32.38% |
| #2 | Oct 2026 | −27.21% |
| #3 | Jul 2024 | −13.49% |
| #4 | Aug 2024 | −10.88% |
| #5 | Sep 2023 | −10.76% |
| Quarter | Return |
|---|---|
| Q3 2025 | +37.56% |
| Q4 2025 | +27.84% |
| Q1 2026 | +24.82% |
| Q2 2026 | +102.81% |
| Q3 2026 | −24.19% |
| Q4 2026 (QTD) | −31.23% |
| Year | Return |
|---|---|
| 2023 | +86.37% |
| 2024 | −7.79% |
| 2025 | +136.99% |
| 2026 | +31.98% |
| Metric | Value |
|---|---|
| 52-Week High | $438.50 (2026-06-30) |
| 52-Week Low | $135.50 (2025-11-21) |
| Current Price | $225.92 |
| 200-Day Moving Average | $283.50 |
| Price vs 200DMA | −20.31% |
| 3-Year Maximum Drawdown | −57.26% (2026-11-05) |
| Current Drawdown from 52W High | −48.48% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 195.8 |
| 3-Year Excess Return vs S&P 500 | +164.12% |
| RS Peak | 379.3 (Jun 2026) |
| RS Trough | 76.4 (Apr 2025) |
| Status | Outperforming Benchmark |
Frequently asked questions
What was LRCX's return for this report period?
LRCX returned −5.52% in the latest monthly window ending 2026-11-13.
Has LRCX outperformed SPY year to date?
YTD LRCX: +31.98% vs SPY: +10.62%.
What is LRCX's 12-month return?
+47.35% over the trailing 12 months.
Is LRCX above or below its 200-day moving average?
Price is −20.31% versus 200DMA ($283.50).
What is the maximum drawdown in the 3-year window?
−57.26% on 2026-11-05.